Activity Description
This CME-accredited lunch symposium features leading experts who will examine the latest clinical trial data and real-world experiences of transformational treatment strategies, and evaluate their potential impact on daily practice.
The first session reviews the safety and efficacy of LAA exclusion for the prevention of ischemic stroke or systemic arterial embolism in cardiac surgery patients without Afib. The second session explores the role of sinus node-sparing hybrid ablation for the treatment of drug-refractory patients with Inappropriate Sinus Tachycardia (IST). Session three assesses post-approval study outcomes of Hybrid Convergent ablation for the treatment of symptomatic longstanding persistent Afib patients who have shown refractoriness or intolerance to AADs. The final session evaluates the safety and efficacy of dual epicardial and endocardial ablation in patients presented with persistent or longstanding persistent Afib.
The presentations are complemented with panel discussions and Q&A sessions that provide an interactive venue for direct faculty engagement.
Date
Friday, May 17, 2024
Times
• 11:30 AM – 12:15 PM EST: Check-In and Lunch Buffet
• 12:15 – 2:00 PM EST: Educational Program
Location
Boston Convention and Exhibition Center • Room 205ABC
Agenda
Agenda | ||
11:30 AM - 12:15 PM |
Check-In and Lunch Buffet |
|
12:15 - 12:20 AM |
Welcome and Introductions |
|
12:20 - 12:35 PM |
LeAAPS Clinical Trial |
|
12:35 - 12:45 PM |
Panel Discussion with Q&A |
|
12:45 – 1:00 PM |
CONVERGE Post-Approval Study |
|
1:00 – 1:10 PM |
Panel Discussion with Q&A |
|
1:10 – 1:25 PM |
HEAL-IST Study |
|
1:25 – 1:35 PM |
Panel Discussion with Q&A |
|
1:35 - 1:50 PM |
DEEP Pivotal Study |
|
1:50 - 2:00 PM |
Panel Discussion with Q&A |
Commercial Support
The activity is supported through an educational grant from AtriCure, Inc.
Joint Providership:
MediaSphere Medical, LLC and Ciné-Med
Faculty
Program Chair and Moderator |
|
Devi Nair, MD, FACC, FHRS |
|
Presenters and Panelists |
|
David DeLurgio, MD, FACC, FHRS |
|
Kenneth Ellenbogen, MD, FHRS |
|
Dhanunjaya Lakkireddy, MD, FACC, FHRS |
|
Richard Whitlock, MD, PhD |
|
CME Accreditation
Activity Goal
This activity is designed to address the following core and team competencies:
Patient care, medical knowledge, practice-based learning and improvement, interprofessional collaboration, and roles and responsibilities.
Target Audience
The symposium is intended to meet the educational needs of Electrophysiologists, Cardiologists, Cardiac and Cardiothoracic Surgeons, Fellows-in-Training, and Allied Healthcare Professionals with a clinical focus of cardiac arrhythmia and left atrial appendage management.
Learning Objectives
Upon completion of this educational activity, participants will be able to:
- Assess the safety and efficacy of LAA exclusion for the prevention of ischemic stroke or systemic arterial embolism in cardiac surgery patients without Afib, who are at elevated risk for these events.
- Examine the role of sinus node sparing hybrid ablation for the treatment of drug-refractory patients with Inappropriate Sinus Tachycardia (IST).
- Discuss the safety and efficacy of Hybrid Convergent ablation for the treatment of symptomatic longstanding persistent AF who are refractory or intolerant to AADs.
- Assess the safety and efficacy of dual epicardial and endocardial ablation in a cohort of patients presented with persistent or longstanding persistent AF.
Accreditation Statement
To support the improvement of patient care, this activity has been planned and implemented by MediaSphere Medical and Ciné-Med. Ciné-Med is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health-care team.
Ciné-Med designates this educational activity for a maximum of 2 AMA PRA CATEGORY 1 Credit(s)™ for Physicians. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Ciné-Med designates this activity for 2 Contact Hours for Nurses.
Disclosure Policy
MediaSphere Medical and Ciné-Med adheres to accreditation requirements concerning industry support of continuing medical education. Speakers are required to openly disclose any limitations of data and/or any discussion of any off-label, experimental, or investigational uses of drugs or devices in their presentations. Speakers will disclose any relationships at the beginning of their presentations.
All MediaSphere Medical and Ciné-Med employees in control of content have indicated that they have no relevant financial relationships to disclose.
It is the policy of MediaSphere Medical and Ciné-Med to ensure balance, independent objectivity, and scientific rigor in all its supported educational programs. All faculty members participating in educational activities are required to disclose to the program audience any real of apparent conflicts of interest held within the past 12 months.
MediaSphere Medical and Ciné-Med implement a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners.
Non-Endorsement Statement
MediaSphere Medical and Ciné-Med verify that sound education principles have been demonstrated in the development of this educational offering as evidenced by the review of its objectives, teaching plan, faculty, and activity evaluation process. MediaSphere Medical and Ciné-Med does not endorse or support the actual opinions or material content as presented by the speaker(s) and/or sponsoring organization.
Commercial Support
The activity is supported through an educational grant from AtriCure, Inc.
Joint Providership:
MediaSphere Medical, LLC and Ciné-Med
“This program is not part of the Heart Rhythm 2024 Official Scientific Sessions as planned by the
Heart Rhythm Society Scientific Sessions Program Committee.
The event is neither sponsored nor endorsed by the Heart Rhythm Society”